Clinical Trials Logo

Filter by:
NCT ID: NCT02847598 Completed - Clinical trials for Systemic Lupus Erythematosus

Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

LILAC
Start date: October 20, 2016
Phase: Phase 2
Study type: Interventional

The primary purpose of the study is to evaluate the efficacy of BIIB059 (litifilimab) in reducing disease activity in participants with systemic lupus erythematosus (SLE) with active cutaneous manifestations and joint involvement (Part A), and in participants with active cutaneous lupus erythematosus (CLE) (Subacute cutaneous lupus erythematosus (SCLE) or chronic CLE, including discoid lupus erythematosus (DLE)) with or without systemic manifestations (Part B). The secondary objective is to evaluate additional efficacy parameters of BIIB059 in reducing SLE/CLE disease activity, pharmacokinetic parameters, safety and tolerability of BIIB059 (Parts A and B).

NCT ID: NCT02847416 Completed - Healthy Subjects Clinical Trials

A Study of Pressure and Flow Characteristics During Inspiration and Expiration Using BreatheMAX® in Healthy Subjects

PFBM
Start date: August 2016
Phase: N/A
Study type: Interventional

the aim of this study are to explore the characteristics of mean airway pressure, oscillatory amplitude and power spectral density (PSD) of oscillatory airway pressure that generate by various loaded and flow rate during expiration and inspiration in healthy subjects and to explore the best loaded and flow rate for airway secretion clearance using the BreatheMAX® device

NCT ID: NCT02846129 Completed - Anesthesia Clinical Trials

Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery

Start date: October 2016
Phase: N/A
Study type: Observational

Incidence of anesthesia related complications in multiple gestation patients undergoing cesarean delivery has not been reported in Thailand. The aim of this study is to identify complications that occur which may derived from different anesthetic techniques used, such as hypotension, uterine atony, postpartum hemorrhage, rate of hysterectomy, blood transfusion and fetal outcome.

NCT ID: NCT02845778 Recruiting - Clinical trials for Pharmacokinetics of Melatonin

Pharmacokinetics of Melatonin Niosomes Oral Gel in Healthy Volunteers

Start date: May 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Melatonin is an endogenous hormone. It is able to promote nighttime sleeping and could induce sleep at daytime in adult and children with the nonpainful diagnostic procedure. However, previous formulation had problems of unstability of product and low oral bioavailability. Melatonin niosomes oral gels are formulated in order to overcome the problem of drug absorption and stability. This study is a randomized, double-blind, three phase crossover design in 15 male volunteers. Melatonin niosomes oral gel will be applied at doses 2.5, 5, and 10 mg with 7 days washout for each period. The pharmacokinetics data, sleep induction effect, and adverse event will be determined.

NCT ID: NCT02840682 Completed - Clinical trials for Neonatal Resuscitation

Outcomes of Neonatal Resuscitation

Start date: April 2016
Phase: N/A
Study type: Observational

The primary objective of this study is to describe mortality of newborns who received basic, advanced or no neonatal resuscitation immediately after birth at Shoklo Malaria Research Unit.

NCT ID: NCT02840266 Recruiting - Hearing Loss Clinical Trials

The Accuracy of Automated Audiometry Application on Smart Phone to Screen Hearing Loss

Start date: August 2015
Phase: N/A
Study type: Observational

The purpose of study is to determine the diagnostic value of Hearing test program on smart phone for detected patients who has hearing loss.

NCT ID: NCT02838420 Active, not recruiting - Clinical trials for Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer

A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Start date: August 3, 2016
Phase: Phase 3
Study type: Interventional

This randomized, multicenter, Phase III, open-label study will evaluate the efficacy and safety of alectinib versus crizotinib and to evaluate the pharmacokinetics of alectinib in asian participants with treatment-naive ALK-positive advanced NSCLC. Participants will be randomized 2:1 into one of the two treatment groups to receive either alectinib (600 milligrams [mg] twice daily [BID]) or crizotinib (250 mg BID) orally, respectively.

NCT ID: NCT02833584 Completed - Dengue Clinical Trials

Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults

Start date: September 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether regular dosage of paracetamol causes transaminitis (hepatitis) and evaluate its potency in the treatment of dengue infection.

NCT ID: NCT02830659 Active, not recruiting - Clinical trials for Cochlear Implantation

Cochlear Implants Registry in Thailand Project

CIRT
Start date: July 2016
Phase: N/A
Study type: Observational

The purpose of this study is to determine the outcome of cochlear implant including post operative hearing ability, developing of language, complication from cochlear implant, quality of life, and success factor of cochlear implant.

NCT ID: NCT02829346 Completed - Clinical trials for Osteoarthritis, Knee

Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty

Start date: October 2012
Phase: Phase 2
Study type: Interventional

This study evaluates the peri-articular tranexamic acid injection in total knee arthroplasty which is an alternative route of administration for blood loss reduction. Half of participants will receive intravenous tranexamic acid injection, while the other half will receive peri-articular tranexamic acid injection during total knee arthroplasty.